Seikagaku Corporation (TYO:4548)

Market Cap	31.29B -15.6%
Revenue (ttm)	36.75B -3.5%
Net Income	1.66B
EPS	30.44
Shares Out	54.60M
PE Ratio	18.82
Forward PE	n/a
Dividend	30.00 (5.24%)
Ex-Dividend Date	Sep 29, 2026

Volume	209,500
Open	570.00
Previous Close	570.00
Day's Range	566.00 - 575.00
52-Week Range	563.00 - 820.00
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business. The company offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the ARTZ, ARTZ Dispo, VISCO-3, JOYCLU, Gel-One, Hylink, and SUPARTZ brands; ophthalmic surgical aids under the OPEGAN and SHELLGAN brand names; surgical aids for endoscopic mucosal resection under the brand nam...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1947
• Employees: 1,142
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4548

Financial Performance

In fiscal year 2026, Seikagaku's revenue was 36.65 billion, a decrease of -6.93% compared to the previous year's 39.37 billion. Earnings were 1.47 billion, an increase of 21.33%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 26, 2026

Data Sources Report a data error